&nbsp;

ocp5HomepageHeroMobile.jpg

Jul 2018

Document

OBSP_july-8-18.html

Aug 2018

Document

obsb-locations-20-8-18.xml

Aug 2018

Document

obsb-locations-20-8-18.html

Aug 2018

Document

OBSP-map14-9-18.html

Sep 2018

Document

obsp-locations-16-10-18.xml

Oct 2018

Document

obsp-locations-oct-18.xml

Oct 2018

Document

obsb-locations-oct-18.html

Oct 2018

Regimen

OBIN(MNT)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - Maintenance Treatment for Refractory Follicular Lymphoma

Drugs Used:

oBINutuzumab

... Show more tags

Quick Link(s):

Regimen Monograph

Dec 2019

Regimen

FC+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

FC(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

oBINutuzumab,

fludarabine (Unfunded),

cyclophosphamide

... Show more tags

Quick Link(s):

Regimen Monograph

May 2019

Regimen

FCM(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

oBINutuzumab,

mitoXANTRONE,

fludarabine (Unfunded),

cyclophosphamide

... Show more tags